Literature DB >> 16214290

The UBQLN1 polymorphism, UBQ-8i, at 9q22 is not associated with Alzheimer's disease with onset before 70 years.

Nathalie Brouwers1, Kristel Sleegers, Sebastiaan Engelborghs, Veerle Bogaerts, Cornelia M van Duijn, Peter Paul De Deyn, Christine Van Broeckhoven, Bart Dermaut.   

Abstract

An intronic polymorphism affecting alternative splicing of exon 8 of ubiquilin 1 (UBQLN1), that is located at a well established Alzheimer's disease (AD) locus on chromosome 9q22, was recently associated with increased risk for late-onset AD. We analyzed this polymorphism in two independent AD samples consisting of patients with an onset age 70 years or less, but did not observe statistically significant association. Our study does not support a major role for this UBQLN1 polymorphism in AD patients with an earlier onset of disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16214290     DOI: 10.1016/j.neulet.2005.08.064

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

Review 1.  Aggresome formation and neurodegenerative diseases: therapeutic implications.

Authors:  J A Olzmann; L Li; L S Chin
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

2.  Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease.

Authors:  Jessie Theuns; Nathalie Brouwers; Sebastiaan Engelborghs; Kristel Sleegers; Veerle Bogaerts; Ellen Corsmit; Tim De Pooter; Cornelia M van Duijn; Peter P De Deyn; Christine Van Broeckhoven
Journal:  Am J Hum Genet       Date:  2006-04-10       Impact factor: 11.025

3.  Ubiquilin-1 is a molecular chaperone for the amyloid precursor protein.

Authors:  Emily S Stieren; Amina El Ayadi; Yao Xiao; Efraín Siller; Megan L Landsverk; Andres F Oberhauser; José M Barral; Darren Boehning
Journal:  J Biol Chem       Date:  2011-08-18       Impact factor: 5.157

4.  Association of UBQLN1 mutation with Brown-Vialetto-Van Laere syndrome but not typical ALS.

Authors:  Paloma González-Pérez; Yubing Lu; Ru-Ju Chian; Peter C Sapp; Rudolph E Tanzi; Lars Bertram; Diane McKenna-Yasek; Fen-Biao Gao; Robert H Brown
Journal:  Neurobiol Dis       Date:  2012-07-03       Impact factor: 5.996

5.  Disrupting the Balance of Protein Quality Control Protein UBQLN2 Accelerates Tau Proteinopathy.

Authors:  Julia E Gerson; Stephanie Sandoval-Pistorius; Jacqueline P Welday; Aleija Rodriguez; Jordan D Gregory; Nyjerus Liggans; Kylie Schache; Xingli Li; Hanna Trzeciakiewicz; Sami Barmada; Lisa M Sharkey; Henry L Paulson
Journal:  J Neurosci       Date:  2022-01-26       Impact factor: 6.709

6.  Ubiquilin overexpression reduces GFP-polyalanine-induced protein aggregates and toxicity.

Authors:  Hongmin Wang; Mervyn J Monteiro
Journal:  Exp Cell Res       Date:  2007-04-06       Impact factor: 3.905

7.  Role of X11 and ubiquilin as in vivo regulators of the amyloid precursor protein in Drosophila.

Authors:  Garrett G Gross; R M Renny Feldman; Atish Ganguly; Jinhui Wang; Hong Yu; Ming Guo
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

8.  Studies of the role of ubiquitination in the interaction of ubiquilin with the loop and carboxyl terminal regions of presenilin-2.

Authors:  Diana L Ford; Mervyn J Monteiro
Journal:  Biochemistry       Date:  2007-07-06       Impact factor: 3.162

9.  The ubiquilin gene family: evolutionary patterns and functional insights.

Authors:  Ignacio Marín
Journal:  BMC Evol Biol       Date:  2014-03-28       Impact factor: 3.260

10.  Ubiquilin-1 and protein quality control in Alzheimer disease.

Authors:  Amina El Ayadi; Emily S Stieren; José M Barral; Darren Boehning
Journal:  Prion       Date:  2013-01-29       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.